Institute Resources
Research Centers
A National Leader in Pediatric Research
The Research Institute at Nationwide Children's Hospital works to enhance the health of children by engaging in high-quality, cutting-edge research. The work we do every day is dedicated to improving the health of Children and their families in Central Ohio and beyond.
Could Waiting Two Minutes Improve How Newborns Recover from Heart Surgery?
A newly funded study is set to determine whether waiting two minutes to clamp a newborn’s umbilical cord after delivery could improve how well he or she recovers from corrective heart surgery.
Read more :: Could Waiting Two Minutes Improve How Newborns Recover from Heart Surgery?
Sickle Cell Patients Should Be Better Monitored for Constipation Prevention
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children’s Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
Read more :: Sickle Cell Patients Should Be Better Monitored for Constipation Prevention
New Potential Autism Susceptibility Genes Identified
Several newly-identified genes may make children more susceptible to developing autism, according to a study from the Autism Genome Project, an international consortium that includes Nationwide Children’s Hospital. These second-phase results appear in Nature.
Read more :: New Potential Autism Susceptibility Genes Identified
Nationwide Children’s Hospital Receives Palliative Care Research Grant
Cynthia Gerhardt, PhD, awarded grant for research to improve care of seriously ill patients
Read more :: Nationwide Children’s Hospital Receives Palliative Care Research Grant
Modified Measles Virus Shows Potential for Treating Childhood Brain Tumors
The use of modified measles virus may represent a new treatment for a childhood brain tumor known as medulloblastoma, according to a new study appearing in Neuro-Oncology. Medulloblastoma is the most common malignant central nervous system tumor of childhood, accounting for about 20 percent of pediatric brain tumors.
Listen Now: Podcasts Dedicated to the Latest Neuromuscular Research
Hosted by Kevin Flanigan, MD, "This Month in Muscular Dystrophy" podcasts highlight the latest in muscular dystrophy and other inherited neuromuscular disease research. During each podcast, authors of recent publications discuss how their work improves our understanding of inherited neuromuscular diseases, and what their work might mean for treatment of these diseases.
New Gene Therapy Study Reverses Effects of Lethal Childhood Muscle Disorder in Mice
Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research shows.
American Academy of Pediatrics Releases New Policy Statement on Choking
American Academy of Pediatrics Releases New Policy Statement on Choking
A new policy statement from the American Academy of Pediatrics (AAP), led by a doctor at Nationwide Children’s Hospital and published in the February 22 online issue of Pediatrics, takes a closer look at preventing choking among children.
New Study Finds Fingers Account for Majority of Pediatric Amputations Requiring Hospitalization
New Study Finds Fingers Account for Majority of Pediatric Amputations Requiring Hospitalization
According to a new study conducted by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children’s Hospital, there were more than 950 children 17 years old and younger admitted to U.S. hospitals for traumatic amputations in 2003.
Gene Mutations May Predispose Patients with Becker Muscular Dystrophy to Early Onset Cardiomyopathy
Gene Mutations May Predispose Patients with Becker Muscular Dystrophy to Early Onset Cardiomyopathy
Investigators in The Research Institute at Nationwide Children’s Hospital have identified a link between specific modifications of the dystrophin gene and the age of cardiac disease onset in patients with Becker muscular dystrophy (BMD).
More Research News
Research News and Highlights
Read more news and highlights from our research faculty
